Macular Neovascularization in Neovascular Age-Related Macular Degeneration: A Systematic Review of OCT Angiography-based Assessments and Challenges in Standardization.

Ophthalmol RetinaMay 8, 2026 (epub)
Clinical ResearchOphthalmology

Cristina Novarese, Chinmayi Vyas, Alessandro Berni et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review evaluated methodologies for assessing macular neovascularization (MNV) in neovascular age-related macular degeneration (nAMD) using OCT angiography (OCTA). It included 155 studies with 9025 patients and highlighted significant methodological heterogeneity in imaging and analysis protocols, which hampers reproducibility. The review emphasizes the need for standardized protocols to enhance clinical utility.

Key findings

  • Included 155 studies with 9025 patients and 9669 eyes evaluated for MNV in nAMD.
  • MNV subtypes identified were type 1 (5059 eyes), type 2 (973 eyes), type 3 (321 eyes), and mixed lesions (138 eyes).
  • OCTA devices varied, with 86 studies using spectral-domain and 64 using swept-source systems.
  • Substantial variability in segmentation strategies and artifact management was noted across studies.

Why it matters

Accurate assessment of MNV is crucial for understanding disease activity and guiding treatment in age-related macular degeneration. The variability in OCTA methodologies can lead to inconsistent results, affecting clinical decision-making and research outcomes.

Source

Published in Ophthalmol Retina. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Ophthalmology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.